MA32983B1 - Procede de preparation de composes optiquement actifs par hydrogenation par transfert - Google Patents

Procede de preparation de composes optiquement actifs par hydrogenation par transfert

Info

Publication number
MA32983B1
MA32983B1 MA34036A MA34036A MA32983B1 MA 32983 B1 MA32983 B1 MA 32983B1 MA 34036 A MA34036 A MA 34036A MA 34036 A MA34036 A MA 34036A MA 32983 B1 MA32983 B1 MA 32983B1
Authority
MA
Morocco
Prior art keywords
preparation
optically active
active compounds
hydrogenation
transport
Prior art date
Application number
MA34036A
Other languages
Arabic (ar)
English (en)
Inventor
Christian Mathes
Michael Foulkes
Martin Kesselgruber
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40344210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32983(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA32983B1 publication Critical patent/MA32983B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/002—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by transformation of a functional group, e.g. oxo, carboxyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)

Abstract

Cette invention concerne un procédé catalytique de préparation de composés optiquement actifs et leur conversion ultérieure en substances médicamenteuses souhaitées. En particulier, le procédé concerne la préparation de (S)-3-(1-diméthylaminoéthyl)phénol par réduction catalytique asymétrique et hydrogénation par transfert, ce qui permet d'obtenir un procédé amélioré pour la formation de substances médicamenteuses telles que la rivastigimine et l'hydrogénotartrate de rivastigimine.
MA34036A 2008-12-24 2009-12-23 Procede de preparation de composes optiquement actifs par hydrogenation par transfert MA32983B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0823554.1A GB0823554D0 (en) 2008-12-24 2008-12-24 Process for the preparation of optically active compounds using transfer hydrogenation
PCT/EP2009/067821 WO2010072798A1 (fr) 2008-12-24 2009-12-23 Procédé de préparation de composés optiquement actifs par hydrogénation par transfert

Publications (1)

Publication Number Publication Date
MA32983B1 true MA32983B1 (fr) 2012-01-02

Family

ID=40344210

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34036A MA32983B1 (fr) 2008-12-24 2009-12-23 Procede de preparation de composes optiquement actifs par hydrogenation par transfert

Country Status (22)

Country Link
US (2) US8415508B2 (fr)
EP (1) EP2382172A1 (fr)
JP (1) JP2012513966A (fr)
KR (1) KR20110098964A (fr)
CN (1) CN102264672A (fr)
AR (1) AR075496A1 (fr)
AU (1) AU2009331493B2 (fr)
BR (1) BRPI0923394A2 (fr)
CA (1) CA2748349A1 (fr)
CL (1) CL2011001563A1 (fr)
CO (1) CO6382153A2 (fr)
EC (1) ECSP11011221A (fr)
GB (1) GB0823554D0 (fr)
IL (1) IL213520A0 (fr)
MA (1) MA32983B1 (fr)
MX (1) MX2011006918A (fr)
MY (1) MY151103A (fr)
NZ (1) NZ593493A (fr)
SG (1) SG172052A1 (fr)
TN (1) TN2011000290A1 (fr)
TW (1) TW201035028A (fr)
WO (1) WO2010072798A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193600B (zh) * 2012-01-07 2016-04-06 浙江九洲药物科技有限公司 卡巴拉汀中间体的制备方法
WO2014200094A1 (fr) * 2013-06-14 2014-12-18 日産化学工業株式会社 Procédé de production d'un composé alcool optiquement actif
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法
CN108752322A (zh) * 2018-09-12 2018-11-06 广州新民培林医药科技有限公司 一种新型Tepotinib衍生物和制备方法及其在抗肿瘤药物中的应用
CN109809967B (zh) * 2019-03-04 2022-03-18 陕西师范大学 一种合成手性醇的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
US4996235A (en) * 1987-11-25 1991-02-26 Eli Lilly And Company 3,4-diphenylbutanamines
JPH0899940A (ja) * 1994-09-30 1996-04-16 Kanegafuchi Chem Ind Co Ltd 光学活性な１−（３，４−ジメトキシフェニル）−２−アミノプロパンの製造法
GB9706321D0 (en) 1997-03-26 1997-05-14 Zeneca Ltd Catalytic hydrogenation
JP3938651B2 (ja) * 2000-04-13 2007-06-27 セントラル硝子株式会社 光学活性α−メチル−ビス−３、５−（トリフルオロメチル）ベンジルアミンの製造方法
WO2002051781A1 (fr) 2000-12-25 2002-07-04 Ajinomoto Co., Inc. Procede permettant de preparer un compose d'halohydrine optiquement actif
CN100439307C (zh) * 2003-07-08 2008-12-03 荷兰联合利华有限公司 化妆活性物质的制备方法
GB0329284D0 (en) 2003-12-18 2004-01-21 Avecia Ltd Process
CN1926083B (zh) * 2004-03-29 2010-12-08 关东化学株式会社 光学活性醇的制备方法
US6939981B1 (en) * 2004-06-25 2005-09-06 Eastman Chemical Company Ruthenium complexes of phosphine-aminophosphine ligands
EP1856036B1 (fr) * 2004-11-08 2016-12-14 Emcure Pharmaceuticals Limited Procede efficace de preparation de (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
WO2006137167A1 (fr) * 2005-06-20 2006-12-28 Kanto Kagaku Kabushiki Kaisha Catalyseur a base de sulfonate et procede de fabrication d'un alcool utilisant ce catalyseur
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2007147897A1 (fr) 2006-06-23 2007-12-27 Basf Se Procédé de fabrication de dérivés de 2-halogéno-1-phényléthanol optiquement actifs et produits obtenus par ce procédé
WO2009132443A1 (fr) 2008-05-01 2009-11-05 Kanata Chemical Technologies Inc. Catalyseurs arène-métal de transition cationiques

Also Published As

Publication number Publication date
JP2012513966A (ja) 2012-06-21
US20100168229A1 (en) 2010-07-01
EP2382172A1 (fr) 2011-11-02
SG172052A1 (en) 2011-07-28
US8415508B2 (en) 2013-04-09
ECSP11011221A (es) 2011-08-31
KR20110098964A (ko) 2011-09-02
TN2011000290A1 (en) 2012-12-17
WO2010072798A1 (fr) 2010-07-01
NZ593493A (en) 2013-03-28
TW201035028A (en) 2010-10-01
AU2009331493B2 (en) 2013-03-07
AR075496A1 (es) 2011-04-06
AU2009331493A1 (en) 2011-07-07
IL213520A0 (en) 2011-07-31
US8637713B2 (en) 2014-01-28
MX2011006918A (es) 2011-07-29
US20130096337A1 (en) 2013-04-18
MY151103A (en) 2014-04-15
CA2748349A1 (fr) 2010-07-01
CO6382153A2 (es) 2012-02-15
CL2011001563A1 (es) 2012-01-13
CN102264672A (zh) 2011-11-30
GB0823554D0 (en) 2009-01-28
BRPI0923394A2 (pt) 2016-01-12

Similar Documents

Publication Publication Date Title
MA32983B1 (fr) Procede de preparation de composes optiquement actifs par hydrogenation par transfert
CY1124873T1 (el) Διεργασια για την παρασκευη (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
HK1134280A1 (fr)
WO2005086860A3 (fr) Procedes d'obtention de cellules produisant de l'insuline
WO2003073998A3 (fr) Production et/ou administration locale d'agents anticancereux par des precurseurs de cellules stromales
IL196626A0 (en) Preparation of 3-[(1r,2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
BR112015013822A2 (pt) método de vaso único para a síntese de cu-ssz-13, o composto obtido através do método e utilização do mesmo
CL2008002246A1 (es) Uso de compuestos derivados de benzamida para tratar trastornos del sistema nervioso central seleccionados entre depresion, ansiedad trastornos psicoticos, trastornos neurologicos, epilepsia, trastornos cardiovasculares, diabetes, dislipidemias, entre otros; compuestos derivados de benzamida; composicion farmaceutica; y uso de la composicion.
MY159955A (en) Certain chemical entities, compositions and methods
WO2008057930A3 (fr) Méthodes destinées à traiter la douleur neuropathique à l'aide d'agonistes des récepteurs de l'acide rétinoïque
MY145759A (en) Method for introducing into a reaction tube of a tube bundle reactor, a partial amount withdrawn from at least one production charge of annular-shaped shell catalysts k
EA201170911A1 (ru) Синтез стирилпиридинов, меченных радиоактивным изотопомf, из предшественников тозилата и их стабильные фармацевтические композиции
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
WO2010071852A3 (fr) Micelles oligonucléotidiques
FR2984763B1 (fr) Procede de preparation d'un catalyseur utilisable en hydroconversion comprenant au moins une zeolithe nu-86
ECSP099716A (es) Extrudidos con enmascaramiento del sabor mejorado
MX2023015523A (es) Compuestos de oligonucleotidos anti-flt1 optimizados para el tratamiento de la preeclampsia y otros desordenes angiogenicos.
EA201200095A1 (ru) Фармацевтические композиции и твердые формы
IL190040A0 (en) Method for the production of 5-fluoro-1,3-dialkyl-1h-pyrazol-4-carbonyl fluorides
FR2984760B1 (fr) Catalyseur utilisable en hydroconversion comprenant au moins une zeolithe et des metaux des groupes viii et vib et preparation du catalyseur
WO2006060692A3 (fr) Agregats metalliques supportes de groupe 4, groupe 5 et groupe 6, preparation de ce materiau et utilisation de ce materiau en tant que catalyseur
CL2008003895A1 (es) Compuestos derivados de 5-o-sustituido 3-n-fenil-1,3,4-oxadiazolonas, composicion farmaceutica, proceso de preparacion, y su uso para el tratamiento de un trastorno influenciado positivamente por la inhibicion de faah tal como trastornos alimenticios y patologias neurologicas y psiquiatricas, entre otras.
MA43158B1 (fr) Composés oxa-diazadispiro possédant une activité contre la douleur
MY167591A (en) Method for producing hydroisomerization catalyst and method for producing lubricant base oil
MY166433A (en) Method for producing hydrogenation catalyst